¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Host Cell Factor C1"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-range mutant
¼÷ÁÖ¹üÀ§µ¹¿¬º¯ÀÌÁÖ
intermediate host
Áß°£¼÷ÁÖ
primary host
Á¾¼÷ÁÖ
paratenic host
¿¬Àå¼÷ÁÖ
reservoir host
º¸À¯¼÷ÁÖ
susceptible host
°¨¼ö¼º¼÷ÁÖ
unnatural host
ºñÈ£Àû¼÷ÁÖ
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÎÀÚ, Ç׎½ÄÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
cell
¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host preference
¼÷ÁÖ¼±È£
host range
¼÷ÁÖ¹üÀ§
host selection
¼÷ÁÖ¼±ÅÃ
host specificity
¼÷ÁÖÆ¯À̼º
host susceptibility
¼÷ÁÖ°¨¼ö¼º
host range mutation
¼÷ÁÖ¹üÀ§º¯ÀÌ, ¼÷ÁÖ¿ªº¯ÀÌ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-parasite relationship
¼÷ÁÖ±â»ýü»óÈ£°ü°è
host-parasite specificity
¼÷ÁÖ±â»ýÃæÆ¯À̼º
host-range mutant
¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ, ¼÷ÁÖ¿ªµ¹¿¬º¯ÀÌü
intermediate host
Áß°£¼÷ÁÖ
natural host
ÀÚ¿¬¼÷ÁÖ
paratenic host
¿¬Àå¼÷ÁÖ
primary host
(¢¡definitive host) ÃÖÁ¾¼÷ÁÖ
reservoir host
º¸À¯¼÷ÁÖ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
T-cell growth factor
T-¼¼Æ÷¼ºÀåÀÎÀÚ
growth factor, B cell (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host attribute
¼÷ÁÖ¼Ó¼º.
host computer
ÁÖ ÄÄÇ»ÅÍ
host controlled variation
¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
host defense
¼÷ÁÖ¹æ¾î
host range
¼÷ÁÖ¹üÀ§, ¼÷ÁÖ¿ª
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-parasite relationship
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
host-parasite relationship
¼÷ÁÖ±â»ýü°ü°è
host-parasite relationships
¼÷ÁÖ ±â»ýÃæ(»ó°ü) °ü°è
host-range mutant
¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
intermediate host
Áß°£¼÷ÁÖ
mutant, host range
¼÷ÁÖ¿ª µ¹¿¬º¯ÀÌÁÖ
pneumonia,in immunocompromised host
¸é¿ª±â´ÉÀúÇϼ÷ÁÖÀÇ (Øóæ¹Ñ¦Òöî¸ù»âÖñ«¡)
relation[ship], host-parasite
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½